This message was sent to ##Email## January 10, 2019     Home  |   About   Subscribe  |   Archive  |   Advertise    ACS CANCER PROGRAMS UPDATES NCDB completeness and default overuse report released NCDB The Default Completeness and Overuse Report for 2016 diagnoses submitted during the 2018 Call for Data has been released. This report gives CoC-accredited programs information about the completeness of required data items. Site-specific reports are available for Breast, Colon, Rectum, Stomach, Esophagus and EG Junction, Lung, Cervical, Endometrium and Ovary. CoC-accredited programs are able to access this report through CoC Datalinks in your CoC Datalinks Activity menu under National Cancer Data Base (NCDB) Data Transmission.  READ MORE 2019 Program Activity Record (PAR) release ACS The updated 2019 PAR is now available to all accredited cancer programs not scheduled for survey in 2019 through CoC Datalinks. All previous PARs are now closed and cannot be re-opened. All cancer programs should only be entering activity in the 2019 version of the SAR or PAR. The PAR will allow you to add, delete or edit any information or uploaded documentation for 2016, 2017, 2018 or 2019 cancer program activity.  READ MORE    SPONSORED CONTENT Promoted by CHAMPS Oncology CHAMPS Oncology Outlook features posts on the industry, careers and more: Developing Goals for CoC Compliance Cancer Registry Abstracting Tips for 2018+ My CHAMPS Oncology CTR Practicum Experience Workspace Tips for the Remote CTR   The CoC and the NAPBC need you! Become a member of the team that works with cancer programs and breast centers to ensure the provision of high-quality, patient-centered care to patients with cancer! If you are a practicing physician who recognizes the impact that CoC and NAPBC accreditation have on patient care, then you are encouraged to complete and submit an application to become a CoC and/or NAPBC surveyor. For additional information, refer to the CoC Surveyor Application or the NAPBC Surveyor Application. 2019 Surveys for National Accreditation for Program Breast Centers NAPBC Breast centers across the U.S. received notifications that preparations are underway for their centers will be surveyed in 2019. Their survey application records are open and ready to be filled with data through the NAPBC portal.  READ MORE .  PRODUCT SHOWCASE Help Doctors Without Borders Today Doctors Without Borders/Médecins Sans Frontières (MSF) is actively recruiting general and trauma surgeons with experience in emergency obstetrics for international missions in developing countries. Learn more 2019 Quality and Safety Conference call for abstracts deadline ACS The American College of Surgeons has issued a call for abstracts to be presented at its 2019 Quality and Safety Conference, July 19-22, at the Washington Convention Center in Washington, D.C. The deadline for submitting abstracts is Feb. 1. Individuals at participating sites are encouraged to submit a 250-word abstract for poster and/or podium presentation. The abstract should relate to surgical quality improvement initiatives; including the development, implementation or validation of best practices. We are also interested in operational best practices relating to workflow around collecting data and reporting. Medical students and medical/surgical trainees are encouraged to submit research for the Best Trainee Abstract Competition. The primary author will be awarded a prize and invited to present at the conference. We encourage submissions from Cancer Programs, including the Commission on Cancer (CoC), National Accreditation Program for Breast Centers (NAPBC) and National Accreditation Program for Rectal Cancer (NAPRC). If you have an idea, start reaching out to your colleagues today. Get your team together and start planning your projects now. For more information or to submit an abstract, click here. Save the Date: 2019 Cluster Programs ACS April 7–9, 2019 – Rosemont (Chicago), Illinois The 2019 Cluster Programs will be three individual one-day programs on consecutive days, in one location, for your convenience. You may attend just one program or all three. Attendees will leave each day with a better understanding of the standards for each accreditation program along with strategies to maximize compliance and ensure the success of your survey. At the conclusion of the session, you will be able to: Define how the accreditation standards and program data can be used as a blueprint for delivering high-quality cancer care Implement best practices for cancer care delivery Formulate strategies to avoid common deficiencies and address the most challenging standards Use the standards as a framework to develop a comprehensive cancer care program Please visit the Cancer Programs website for further information as it becomes available.     .  SPONSOR SPOTLIGHT     Register today for the CAnswer Forum Live ACS – Cancer Programs Register today for the CAnswer Forum Live on Jan. 23. This 60-minute live webinar features important information from the Cancer Programs and answers to the CoC, NAPBC and/or NAPRC standard questions submitted by you. Submit your questions, and register for the live broadcast! For additional information, contact Sue Rubin, or visit the CAnswer Forum webpage.  READ MORE 2018 DCIS Special Study concludes ACS The 2018 DCIS Special Study closed on Oct. 26, 2018. Data gleaned from the study are currently undergoing analysis with Principal Investigator Dr. Shelley Hwang’s team at Duke University. We expect preliminary results to be available in mid-2019; results from the study will be shared with staff at Commission on Cancer (CoC)-accredited sites after publication. On behalf of the Special Studies team, thank you to all registrars and co-registrars for your determination, your hard work and the timely submission of your data. We are fortunate to work alongside such a talented group of professionals. CoC-accredited institutions with a compliant Special Study rating have earned credit toward CoC Standard 5.7, Special Studies, for 2018. National Accreditation Program for Breast Centers (NAPBC) institutions with a compliant Special Study rating have earned credit toward NAPBC Standard 6.1, Quality and Outcomes, for 2018. If you have questions about the Special Study, please reach out to specialstudy@facs.org.    SPONSORED CONTENT Promoted by InformedDNA Determining Breast Cancer Risk and Screening Methodologies Different Breast Cancer Genes Identify Different Risks, Not All Lead to Preventative Mastectomy Rebecca Sutphen, MD, FACMG, shares advice on when genetic counseling is beneficial for patients Genetics Services Programs from the nation’s largest, lab-independent, full-time staff of genetics experts in the U.S. A Guide to Achieving Measurable Results in Genetic Benefits Management   AJCC Cancer Staging Manual, 8th Edition Kindle version available now AJCC The AJCC Cancer Staging Manual, Eighth Edition is the first edition to have an electronic book (ebook) version. It is available for purchase now on Amazon and is the most current version of the manual (September 2018). Since 1977, the American Joint Committee on Cancer (AJCC) has published eight editions of cancer staging manuals using contemporary, evidenced-based literature to build a common language of cancer for the care of cancer patients by clinicians and for the cancer surveillance community. The print version of the eighth edition was first published in October 2016 and went into effect for all cancer cases diagnosed on or after Jan. 1, 2018. The eighth edition presents evidence-based revisions for the staging of cancer for a number of organ sites. The chapters include the rationale and rules for staging; the definitions of tumor, lymph node involvement and metastasis; stage groupings; and histologic grade. There have been updates since the first printing of the eighth edition, all of which are incorporated in this ebook version available through Amazon’s Kindle. The Kindle version can be used on any device (PC, MAC, iPhone, iPad, Android) with the free Kindle app. The electronic version allows for highlighting, adding notes and bookmarks and creating flashcards. The AJCC has a curated FAQ document to address common questions that can be accessed at cancerstaging.org. All other questions related to the eighth edition can be sent to ajcc@facs.org.  READ MORE .  PRODUCT SHOWCASE Cancer Coding - Budget Preserving Processes Need to automate cancer coding at Budget Preserving costs? Let AI do the bulk coding and preserve valuable staff time for the most cryptic. HORIZON suite automates NAACR 2018 for 100% of your reportability assessments and 90%+ of your coding at better than manual accuracy, while undercutting manual costs. With ever-tightening budgets and workloads rising continuously and more data for analysis being demanded, www.hla-global.com is your best option for the future.  HEALTH CARE NEWS AND UPDATES Robotic surgery for hepatic neoplasms: Where does it fit in the minimally invasive surgery landscape? ACS Robotic surgery is commonly performed for cancers of the prostate and uterus but is still evolving for other tumors, such as colon and rectal malignancies. In 2017, more than 693,000 robotic-assisted procedures were performed in the U.S., and the overall market for surgical robotic systems was valued at more than $2.4 billion. An even more specialized tumor site being treated with robotic surgery is neoplastic disease of the liver.  READ MORE Data support accelerated radiotherapy as standard of care for breast cancer Healio When followed by a tumor bed boost, hypofractionated and conventionally fractionated whole-breast irradiation appeared to yield comparable 3-year outcomes among patients with breast cancer, according to a randomized noninferiority phase 3 study published in Journal of Clinical Oncology. Thus, hypofractionated whole-breast irradiation (HF-WBI) should be the standard of care regardless of tumor bed boost, chemotherapy and larger breast size.  READ MORE New breath test for cancer currently under trial Medical News Today A clinical trial has just launched to assess the effectiveness of a newly developed breath test that could help diagnose multiple forms of cancer. Researchers from the Cancer Research United Kingdom Cambridge Institute have recently developed an innovative breath test. They say that it will assist in the diagnosis of several types of cancer.  READ MORE Overactive bladder linked to prostate cancer ADT Cancer Therapy Advisor Androgen deprivation therapy (ADT) for prostate cancer is associated with an increased risk of overactive bladder (OAB), a finding consistent with an inhibitory role of androgen in modulating male voiding dysfunction, according to a new study. Compared with ADT recipients, healthy men and men receiving alpha blockers for benign prostatic hyperplasia (BPH) had a significant 98 percent and 30 percent decreased risk of OAB, respectively, after adjusting for numerous potential confounding factors. Increased ADT duration increased the cumulative risk of OAB.  READ MORE Persistent hot flashes increase breast cancer risk in women Medscape Postmenopausal women who experience persistent hot flashes are more likely to be diagnosed with breast cancer than women who never experience vasomotor symptoms (VMS), but they are not more likely to die from it, a new long-term analysis from the Women's Health Initiative (WHI) suggests.  READ MORE New molecule stops cancer from 'tricking' the immune system Medical News Today New research throws a wrench in cancer's deception plans. A molecule that scientists have designed stops cancerous cells from tricking the immune system into sustaining their growth. Cancer has many sly ways in which it tricks the immune system into sparing it or even into boosting its spread.  READ MORE Artificial intelligence in skin cancer: Man vs machine redux Cancer Therapy Advisor The incidence of skin cancer is increasing in fair-skinned individuals, in the United States and worldwide, and is putting pressure on health care costs and specialist services. Estimates predict that as high as 20 percent of Americans will get skin cancer, with approximately 230,000 new cases of malignant melanoma worldwide and 50,000 resulting deaths. Although melanoma represents 5 percent of all skin cancers — it is the most deadly, with a high risk of metastasis — and it is thought to be the cause of 75 percent of skin cancer deaths.  READ MORE  IMPORTANT DATES AND DEADLINES Date Event Location April 7-9, 2019 Cluster Programs Rosemont, IL   The Brief Connect with AJCC Connect with CoC Connect with NAPBC Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version  Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit Ashley Harrington, Senior Content Editor, 469-420-2642 | Contribute news Disclaimer: The Brief is a digest of news selected for the Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC), both quality programs of the American College of Surgeons, from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The Cancer Programs do not endorse any of the advertised products and services. Opinions expressed in the articles are those of the authors and not of the American College of Surgeons, and the Cancer Programs. American College of Surgeons 633 N Saint Clair Street | Chicago, IL, 60611-3211  | 800-621-4111 | Contact Us  Learn how to add us to your safe sender list so our emails get to your inbox. 7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063